Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
06-08 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
06-08 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
27 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/27/3088503/24603/en/Repligen-Announces-Publication-of-the-Company-s-2024-Corporate-Sustainability-Report.html
22 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/22/3086481/24603/en/Repligen-Corporation-to-Present-at-William-Blair-Growth-Conference.html
07 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/07/3075987/24603/en/Repligen-Corporation-to-Present-at-Upcoming-May-Investor-Conferences.html
29 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/29/3070066/24603/en/Repligen-Reports-First-Quarter-2025-Financial-Results.html
15 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/15/3061602/24603/en/Repligen-to-Report-First-Quarter-2025-Financial-Results.html
08 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/08/3057502/24603/en/Repligen-Appoints-Jacob-Johnson-As-Vice-President-Investor-Relations.html
ABOUT THIS PAGE
Repligen Corporation is a supplier offers 8 products (APIs, Excipients or Intermediates).
Find a price of FAST FLOW IMMOBILIZED RECOMBINANT PROTEIN A IN MASSACHUSETTS bulk offered by Repligen Corporation
Find a price of ULTRAPURE RECOMBINANT PROTEIN A bulk offered by Repligen Corporation
Find a price of IMMOBLIZED (R) PROTEIN (A) TM, IPA-500 bulk offered by Repligen Corporation
Find a price of THERAPEUTIC RECOMBINANT PROTEIN A bulk offered by Repligen Corporation
Find a price of FACILITIES LOCATED IN CAMBRIDGE, MA bulk offered by Repligen Corporation
Find a price of IMMOBILIZED PROTEIN A IPA-400HC bulk offered by Repligen Corporation
Find a price of IMMOBILIZED RECOMBINANT PROTEIN A bulk offered by Repligen Corporation
Find a price of RG2133(TRIACETYL URIDINE) DRUG SUBSTANCE bulk offered by Repligen Corporation